Basic info
Industry
biotechnology
Sectors
Biotechnology
Medicinal chemistry
Emergency Medicine
Small Molecule Drug Discovery
inflammatory diseases
pharmaceuticals
Immuno-oncology
arginase
chitinase
Immunotherapy
fibrotic diseases
Respiratory diseases
Alternative Medicine
Medical
Small molecule immunomodulators
Cancer
Date founded
2012
Funding rounds raised
Total raised
$7.3M
from 2 investors over 2 rounds
O
OncoArendi Therapeutics raised $3.2M on January 19, 2015
Investors: New Europe Ventures
O
OncoArendi Therapeutics raised $7.3M on December 23, 2014
Investors: NCBR+ Sp. z o.o.